Right ventricular sugars and fats in chronic thromboembolic pulmonary hypertension.

[1]  D. Stewart,et al.  Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. , 2016, European heart journal cardiovascular Imaging.

[2]  N. Voelkel,et al.  Increased Right Ventricular Fatty Acid Accumulation in Chronic Thromboembolic Pulmonary Hypertension. , 2015, Annals of the American Thoracic Society.

[3]  P. Pibarot,et al.  Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension , 2022 .

[4]  Sebastien Bonnet,et al.  A miR-208–Mef2 Axis Drives the Decompensation of Right Ventricular Function in Pulmonary Hypertension , 2015, Circulation research.

[5]  Sotirios D. Zervopoulos,et al.  A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension , 2013, Journal of Molecular Medicine.

[6]  J. Bigbee,et al.  Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension , 2013, Circulation. Heart failure.

[7]  Vittorio Pengo,et al.  Chronic thromboembolic pulmonary hypertension. , 2006, Journal of the American College of Cardiology.

[8]  S. Archer,et al.  Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[9]  A. Noordegraaf,et al.  The role of the right ventricle in pulmonary arterial hypertension , 2011, European Respiratory Review.

[10]  C. Long,et al.  Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure , 2009, Circulation.

[11]  M. Sarai,et al.  123I-BMIPP fatty acid analogue imaging is a novel diagnostic and prognostic approach following acute myocardial infarction. , 2009, Singapore medical journal.

[12]  A. Coats,et al.  Ethical authorship and publishing. , 2009, International journal of cardiology.

[13]  I. Haber,et al.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle , 2009, Journal of Molecular Medicine.

[14]  J. Bronzwaer,et al.  Right coronary artery flow impairment in patients with pulmonary hypertension. , 2007, European heart journal.

[15]  Y. Magata,et al.  Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo , 2007, Annals of nuclear medicine.

[16]  Y. Kagaya,et al.  Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. , 2005, Journal of the American College of Cardiology.

[17]  N. Tamaki,et al.  BMIPP compared with PET metabolism , 1999, The International Journal of Cardiac Imaging.

[18]  S. Eddahibi,et al.  Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. , 1998, The American journal of physiology.

[19]  Y. Sawada,et al.  Detection of impaired fatty acid metabolism in right ventricular hypertrophy: Assessment by I-123 β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography , 1997, Annals of nuclear medicine.

[20]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.

[21]  R. Gibbons,et al.  Position statement: clinical use of cardiac positron emission tomography. Position paper of the Cardiovascular Council of the Society of Nuclear Medicine. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.

[23]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.